Non-tubal ectopic pregnancy treatment experiences of a tertiary care center
Archives of Gynecology and Obstetrics · 2024
DOI: 10.1007/s00404-023-07338-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, 2024. Verfasst von Yıldız Akdaş Reis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Etlik Zübeyde Hanım Maternity and Women's Health Teaching and Research Hospital, Ankara, Turkey. yildizakdas…. Hauptthemen laut MEDLINE: Tertiary Care Centers, Pregnancy, Ectopic, Methotrexate, Abortifacient Agents, Nonsteroidal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
AIM: To evaluate the incidence, the risk factors, and the treatment outcomes of Non-tubal ectopic pregnancies (NTEP) treated in a tertiary care center. MATERIAL AND METHODS: A total of 110 NTEP cases treated between 2014 and 2019 were included in the retrospective study. The study cohort was divided into 6 groups according to the pregnancy localization: 87 cesarean scar pregnancies (CSPs), 7 ovarian pregnancies, 6 interstitial pregnancies, 4 rudimentary horn pregnancies, 4 abdominal pregnancies, and 2 cervical pregnancies. One woman rejected all treatment modalities. Demographic characteristics, treatment modalities, and outcomes of each group were evaluated. RESULTS: In the study cohort, expectant management was performed in one (0.9%) woman. The methotrexate (MTX) treatment was administered in 29 (26.3%) women. Seventeen (15.4%) women underwent surgery, and 63 (57.2%) women underwent manual vacuum aspiration (MVA). A woman rejected all treatment modalities. Although 70.1% (n = 61) of CSPs were cured with MVA, 24.1% (n = 21) of them were treated with a single-dose MTX regimen in addition to MVA. The higher mean gestational sac size (33,9 ± 12,96 mm vs. 17,34 ± 9,87 mm), the higher mean gestational week (8,43 ± 1,16w vs. 6,66 ± 1,49w), the presence of fetal heartbeat (FHB) (90.5% vs. 26,2%) and the history of pelvic ınflammatory disease (PID) (38.1% vs. 6,6%) were found in the CSPs with MVA treatment failure (p < 0.05). CONCLUSION: The management of NTEPs should be individualized according to the clinical and ultrasonographic findings. The size of the ectopic pregnancy mass, the gestational week, the presence of FHB, and the PID history were the predictive factors for the failure of MVA in CSP cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Etlik Zübeyde Hanım Maternity and Women's Health Teaching and Research Hospital, Ankara, Turkey. yildizakdasreis@hotmail.com.
- Department of Obstetrics and Gynecology, Etlik Zübeyde Hanım Maternity and Women's Health Teaching and Research Hospital, Ankara, Turkey.
- Bingöl Maternity and Children Hospital, Bingöl, Turkey.
- Department of Perinatology, Etlik City Hospital, Ankara, Turkey.
- Department of Obstetrics and Gynecology, Bilkent City Hospital, Ankara, Turkey.
ORCID-Profile: Yıldız Akdaş Reis, Arife Akay, Merve Özkan, Seval Yılmaz Ergani, Sadullah Özkan, Tuğba Kınay, Salim Erkaya
Zitieren
APA
Akdaş Reis, Y., Akay, A., Özkan, M., Yılmaz Ergani, S., Özkan, S., Kınay, T., & Erkaya, S. (2024). Non-tubal ectopic pregnancy treatment experiences of a tertiary care center. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-023-07338-5
Vancouver
Akdaş Reis Y, Akay A, Özkan M, Yılmaz Ergani S, Özkan S, Kınay T, et al. Non-tubal ectopic pregnancy treatment experiences of a tertiary care center. Archives of Gynecology and Obstetrics. 2024. doi:10.1007/s00404-023-07338-5
BibTeX
@article{AkdaReis2024,
author = {Akdaş Reis, Yıldız and Akay, Arife and Özkan, Merve and Yılmaz Ergani, Seval and Özkan, Sadullah and Kınay, Tuğba and Erkaya, Salim},
title = {Non-tubal ectopic pregnancy treatment experiences of a tertiary care center},
journal = {Archives of Gynecology and Obstetrics},
year = {2024},
doi = {10.1007/s00404-023-07338-5}
}
EUVIMED